1.
|
Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 3 to 21 Sponsor: NCI Protocol IDs: NCI-2011-02616, ACNS0822, CDR0000688443, U10CA098543, COG-ACNS0822, NCT01236560
|
|
2.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 3 to 21 Sponsor: NCI Protocol IDs: NCI-2011-02600, ACNS0927, U10CA098543, U10CA97452, COG-ACNS0927, NCT01189266
|
|
3.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 21 and under Sponsor: NCI Protocol IDs: PBTC-033, PBTC-033, NCT01514201
|
|
4.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Any age Sponsor: Other Protocol IDs: 05-122, MSKCC-05122, NCT00445965
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 3 to 21 Sponsor: Other Protocol IDs: 24549, NCT00879437
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: 6 months to 17 years Sponsor: Other Protocol IDs: CDR0000066490, BC-BT-10, NCT00003458
|
|
7.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 3 to 18 Sponsor: Other Protocol IDs: DFCI 10-321, NCT01182350
|
|
8.
|
Phase: Phase II Type: Natural history/Epidemiology, Treatment Status: Active Age: 1 to 25 Sponsor: NCI, Other Protocol IDs: 10-206, NCT01288235
|
|
9.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 months to 23 years Sponsor: Other Protocol IDs: ACH-CNS-001, NCT00876993
|
|
10.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and undere Sponsor: NCI Protocol IDs: PEDSBRN0008, SU-01062010-4642, 1RC2CA148491-01, NCT01058850
|
|
11.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Under 19 at diagnosis Sponsor: NCI Protocol IDs: NCI-2011-02539, 10-C-0219, CDR0000687467, NCI-10-C-0219, 8449, NCT01226940
|
|
12.
|
Phase: Phase I Type: Treatment Status: Active Age: 3 to 25 Sponsor: Other Protocol IDs: 2009LS136, 1004M81213, NCT01400672
|
|
13.
|
Phase: No phase specified Type: Treatment Status: Active Age: 3 to 30 Sponsor: Other Protocol IDs: HGG, NCT00890786
|
|
14.
|
Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 2 to 25 Sponsor: Other Protocol IDs: 2005P001629, NCT01115777
|
|
15.
|
Phase: No phase specified Type: Treatment Status: Active Age: 19 months to 20 years Sponsor: Other Protocol IDs: PRO08030085, NCT01130077
|